Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Phase . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel solid-phase synthesis of goserelin using CDI activation improves yield and purity. Cost-effective manufacturing for pharmaceutical intermediates.
Advanced solid-phase synthesis of liraglutide intermediates using microwave technology. Delivers high purity, reduced costs, and reliable supply chain solutions.
Patent CN103880776A reveals a novel solid-phase grinding method for 2-amino-5-alkyl-1,3,4-thiadiazoles, offering high yields and simplified processing for pharmaceutical intermediates.
Patent CN102464702A reveals a high-purity Boc-solid phase synthesis for Leuprorelin Acetate, offering superior environmental safety and supply chain reliability for pharmaceutical manufacturers.
Patent CN101792487A details a robust solid-phase method for Laterocidin. Overcomes extraction limits with high-purity cyclic peptide manufacturing capabilities.
Novel solid-phase synthesis method for triazine libraries offering high purity and yield for anticancer drug discovery and commercial manufacturing.
Novel AM Resin method improves purity and yield for semaglutide manufacturing. Reduces impurities and simplifies purification for reliable supply chain partners.
Patent CN107880111B reveals a novel Glu-21 side-chain anchoring method for Liraglutide, enhancing coupling efficiency and purity for scalable manufacturing.
Novel Ru/C catalyzed hydrogenation and solvent-free isomerization route for high-purity liquid crystal intermediates with over 90% yield.
Patent CN107778350B details a high-yield solid-phase synthesis for Romidepsin, offering superior purity and cost reduction in pharmaceutical manufacturing.
Novel solid-phase route enhances purity and yield for liposome drug carriers reducing production complexity significantly while ensuring scalable manufacturing processes for global pharmaceutical supply chains demanding high quality standards.
Patent CN112574285B reveals a novel solid-liquid phase synthesis for disulfide-bonded polypeptides, offering high purity and simplified manufacturing for pharmaceutical intermediates.
Efficient fragment-based SPPS method for Nangibotide offering high purity and scalable manufacturing solutions for global pharmaceutical partners seeking reliable supply.
Patent CN104710509B reveals low-temperature solid-phase synthesis for over 99% purity Eptifibatide, ensuring supply chain stability and reduced impurities for global buyers.
Novel solid-liquid hybrid method for Semaglutide fragments improves yield to 49% and purity to 99.9%, ensuring reliable supply chain.
Patent CN108218957B details a novel hybrid synthesis for AMG416, offering improved purity and reduced environmental impact for reliable pharmaceutical intermediate supply chains.
Patent CN117186186A reveals a hybrid solid-liquid synthesis method for high-purity cyclic peptides, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107827956A details solid-phase synthesis of Reniochalistatin E. Offers high purity and reduced racemization for reliable pharmaceutical intermediates supply chains.
Patent CN102020703A details a robust solid-phase synthesis for fatty acyl cyclic depsipeptides. This method offers high purity and scalability for antibiotic intermediate manufacturing.
Novel soluble solid-phase carrier technology reduces solvent waste and reactor size for scalable polypeptide drug production like Eptifibatide.